Results 21 to 30 of about 74,576 (156)

Efficacy and safety of low‐dose imatinib in an elderly patient with mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR‐ABL1

open access: yesClinical Case Reports, 2021
Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.
Yusuke Okayama   +7 more
doaj   +1 more source

Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (Alliance)

open access: yesHaematologica, 2014
Allogeneic stem cell transplantation is the standard approach to Philadelphia chromosome positive acute lymphoblastic leukemia. We hypothesized that imatinib plus sequential chemotherapy will result in significant leukemia cell cytoreduction in patients ...
Meir Wetzler   +12 more
doaj   +1 more source

Modeling Philadelphia chromosome positive leukemias [PDF]

open access: yesOncogene, 2001
The Ph chromosome has been genetically linked to CML and ALL. Its chimeric fusion gene product, BCR-ABL, can generate leukemia in mice. This review will discuss selected model systems developed to study BCR-ABL induced leukemia and focuses on what we have learned about the human disease from these models.
S, Wong, O N, Witte
openaire   +2 more sources

Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia

open access: yesHaematologica, 2019
To shed light onto the molecular basis of Philadelphia chromosome-positive acute lymphoblastic leukemia and to investigate the prognostic role of additional genomic lesions, we analyzed copy number aberrations using the Cytoscan HD Array in 116 newly ...
Anna Lucia Fedullo   +18 more
doaj   +1 more source

Philadelphia chromosome-positive Acute Lymphoblastic Leukemia [PDF]

open access: yesHematology, 2015
Philadelphia chromosome-positive Acute Lymphoblastic ...
FORGHIERI, Fabio   +2 more
openaire   +3 more sources

Mutations Associated with Imatinib Mesylate Resistance - Review

open access: yesFolia Medica, 2018
Chronic myeloid leukemia (CML) arises from the fusion of the BCR and the ABL1 genes. The BCR gene (chromosome 22q11.2) and the ABL1 gene (chromosome 9q34) fuse together due to reciprocal chromosome translocation forming the Philadelphia chromosome (Ph ...
Linev Alexandar J.   +5 more
doaj   +1 more source

BCR/ABL1 fluorescence in situ hybridization fusion signals on both copies of chromosome 22 in a Philadelphia-masked chronic myeloid leukemia case: implication for the therapy

open access: yesHematology Reports, 2021
The cytogenetic hallmark of Chronic Myeloid Leukemia (CML) is the presence of Philadelphia (Ph) chromosome, which results from a reciprocal translocation t(9;22)(q34;q11).
Silvia Soriani   +9 more
doaj   +1 more source

Philadelphia chromosome duplication as a ring-shaped chromosome [PDF]

open access: yesMolecular Cytogenetics, 2016
La obtención de una segunda copia del cromosoma Filadelfia es uno de los principales cambios cromosómicos secundarios relacionados con la evolución clonal de las células con t(9;22) en la leucemia mielógena crónica. Esta ganancia provoca la adquisición de otra copia del gen de fusión BCR/ABL1.
César Borjas-Gutiérrez   +1 more
openaire   +2 more sources

“Preleukemic or smoldering” chronic myelogenous leukemia (CML):BCR-ABL1 positive: A brief case report

open access: yesLeukemia Research Reports, 2015
Chronic myelogenous leukemia (CML), in the Chronic Phase (CP), is often suspected as a result of a complete blood count (CBC), which shows increased granulocytes, mostly mature including a peak in myelocytes, increased basophils, and rarely blasts and/or
John M. Bennett   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy